A phase 2, multicenter, open‐label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma - Kudchadkar - 2015 - Cancer Medicine - Wiley Online Library
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
Suppression of endogenous Survivin by YM155 occurs through a... | Download Scientific Diagram
YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation
YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice | Oncotarget
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo
Generation of reactive oxygen species is the primary mode of action and cause of survivin suppression by sepantronium bromide (YM155) - RSC Medicinal Chemistry (RSC Publishing)
YM155 inhibits formation and expansion of gastric cancer spheres. A.... | Download Scientific Diagram
YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation
The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma | Oncotarget
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer - Annals of Oncology
YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair - ScienceDirect
YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction - ScienceDirect